Catalyst Pharmaceuticals (CPRX) Operating Expenses (2010 - 2026)
Catalyst Pharmaceuticals' (CPRX) quarterly Operating Expenses came in at $76.2 million in Q1 2026, down 2.43% YoY from $78.1 million in Q1 2025, and down 16.1% on a QoQ basis from $90.8 million in Q4 2025.
Catalyst Pharmaceuticals (CPRX) Operating Expenses (2010 - 2026) Analysis & Trends
Catalyst Pharmaceuticals (CPRX) has 17 years of Operating Expenses data on file, last reported at $76.2 million in Q1 2026.
- Quarterly Operating Expenses fell 2.43% year-over-year to $76.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $329.3 million (up 8.58% YoY) and the FY2025 annual result came in at $331.2 million, up 11.67% from the prior year.
- Operating Expenses slipped to $76.2 million in Q1 2026, from $90.8 million in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $139.9 million in Q3 2023 to a low of $24.5 million in Q2 2022.
- A 5-year average of $66.3 million and a median of $71.4 million in 2024 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2023 — Operating Expenses surged 335.18% — and 2024, when it slumped 44.39%.
- Tracing CPRX's Operating Expenses over 5 years: stood at $30.0 million in 2022, then surged by 129.92% to $68.9 million in 2023, then climbed by 14.67% to $79.0 million in 2024, then gained by 14.93% to $90.8 million in 2025, then retreated by 16.1% to $76.2 million in 2026.
- The last three Operating Expenses figures came in at $76.2 million (Q1 2026), $90.8 million (Q4 2025), and $82.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Catalyst Pharmaceuticals | 3.85 Bn | 3.09 Bn | 134.92 Mn | 76.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.16 Mn |
| Dec 31, 2025 | 90.77 Mn |
| Sep 30, 2025 | 82.13 Mn |
| Jun 30, 2025 | 80.27 Mn |
| Mar 31, 2025 | 78.05 Mn |
| Dec 31, 2024 | 78.98 Mn |
| Sep 30, 2024 | 77.79 Mn |
| Jun 30, 2024 | 68.46 Mn |
| Mar 31, 2024 | 71.38 Mn |
| Dec 31, 2023 | 68.88 Mn |
| Sep 30, 2023 | 139.88 Mn |
| Jun 30, 2023 | 52.88 Mn |
| Mar 31, 2023 | 49.76 Mn |
| Dec 31, 2022 | 29.96 Mn |
| Sep 30, 2022 | 32.14 Mn |
| Jun 30, 2022 | 24.54 Mn |
| Mar 31, 2022 | 25.72 Mn |
| Dec 31, 2021 | 25.57 Mn |
| Sep 30, 2021 | 21.95 Mn |
| Jun 30, 2021 | 20.53 Mn |